CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 10-Q Report Quarterly Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Grant or award Chief Financial Officer acquired 66,100 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change
- 4 Planned sale Chief Commercial Officer sold 143 shares at $12.12 ($1,733)
- 4 Planned sale SVP, Head of Finance & Admin. sold 1,343 shares at $11.38 ($15,283)
- 4 Planned sale Chief Scientific Officer sold 2,153 shares at $11.38 ($24,501)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Chief Medical Officer sold 1,343 shares at $11.83 ($15,888)
- 4 Planned sale CEO & President sold 4,061 shares at $11.83 ($48,042)
- 4 Planned sale SVP, Head of Finance & Admin. sold 917 shares at $11.83 ($10,848)
- 4 Planned sale Chief Scientific Officer sold 1,094 shares at $11.83 ($12,942)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 13 of 40 · 796 filings